Please login to the form below

Not currently logged in
Email:
Password:

People, March, 2007

Bristol-Myers Squibb has appointed Frank Pasqualone as European vice president and general manager

Bristol-Myers Squibb (BMS) has appointed Frank Pasqualone as European vice president and general manager, UK. In his new role, Frank will report to Beatrice Cazala, president of BMS Europe, Middle East and Africa. Frank joins from BMS in the US where most recently he was senior vice president of oncology. During this time, he was responsible for the successful launches of a number of the company's cancer products including Erbitux and Sprycel. He has worked at BMS since 1986 and has held positions in market research, policy and planning, franchise development and marketing. He replaces UK vice president and general manager, David Veitch, who has been promoted to senior vice president, Europe marketing and brand commercialisation.

Pfizer has appointed John Young as country manager for the UK, replacing Olivier Brandicourt who has been appointed senior vice president/general manger of the firm's US cardiovascular and metabolic business unit. Previously, John was regional director for Pfizer Australia and New Zealand.

ProStrakan has appointed Callum Spreng as corporate communications director. Callum will be responsible for strategic communications to ProStrakan investors, City analysts, business and specialist press, and staff. Callum joins the company from media group, SMG, where he was communications director for nine years.

Azmina Khanbhai has been hired as medical affairs manager for nephrology for Amgen in the UK and Ireland. In her new role, she will lead all medical aspects of the nephrology business, including key opinion leader liaison and project management. Azmina joins from Abbott Laboratories.

Alan Boyce has been appointed chief operating officer of Synexus, where he will be responsible for the company's operations in the UK, Poland, Hungary, Bulgaria, India and South Africa. Alan joins Synexus from Kendle where he was vice president of operations, Europe, Middle East and Africa. Prior to his time at Kendle, he worked for 18 years at Procter & Gamble working in both the UK and the US, culminating as commercial director for the UK and Ireland.

Elbion has appointed Dr Koenraad Blot as chief medical officer. Dr Blot has 15 years' international pharma industry experience, most recently was executive director of clinical research at Theratechnologies, Canada. Prior to this, he worked at Pfizer in scientific affairs, medical operations and clinical research in Canada, the US and Belgium.

Synovate Healthcare has announced four promotions: Bob Douglas as managing director, global custom and Marianne Purdie as managing director, Europe custom, Rebecca Webster as senior vice president, syndicated services and Rhoda Schmuecking, senior vice president, global therapy monitors. Bob was managing director of Synovate Healthcare, Europe and Asia. Marianne was previously global branded solutions director. Rebecca will be responsible for therapy monitors and salesforce effectiveness monitor, Jigsaw. Rhoda will be developing existing therapy monitors and launching new monitors. In addition, Virginia Mount has been appointed to Synovate Healthcare's global executive committee.

Bespak has promoted Chris Halling to head of corporate communications. Chris, who has been at the firm since 2001, will assist the corporate management team with communications to shareholders, the financial community and internally. He will also continue to manage the firm's business marketing activities including public relations, advertising literature and conferences.

Fleishman-Hillard London has made four new hires: Mitali Rajan, James Smith, Lindsay Fowlston and Natasha Rydlewski. Mitali joins as senior account manager and will be leading Novartis, Aclasta and Schering-Plough accounts. James joins as account manager and will be working on the Novartis Galvus account, as well as on new business. Lindsay, who joins as senior account executive, will also be working on the Novartis Galvus account and the UCB Cimzia account. Natasha also joins as account executive working on the Novartis Galvus account and the Oticon account.

~

Dr Kamran Abassi has been appointed chief executive officer of OnMedica. Dr Abassi, editor of the Journal of the Royal Society of Medicine and former deputy editor and acting editor of the British Medical Journal, replaces OnMedica founding director and CEO Brad Wilson.

ScopeMedical has made two new hires: Rebecca Drake and Michelle Utton-Mishra. Rebecca joins the firm as senior account executive. She worked as a scientific researcher for 10 years before moving into publishing. Michelle joins as a senior medical writer with three year's internationl writing experience.

Weber Shandwick has hired Euro RSCG Life PR's managing director Rachel Pay. Rachel joins the agency as European healthcare managing director, reporting to CEO Colin Byrne and global healthcare president Laura Schoen.

Dewar Advertising has made two new hires: Frankie Laws and John Hartley. Frankie joins the firm from Ogilvy Healthworld Advertising and will be developing the agency's consumer portfolio. John will spearhead specialist education projects, pulling together Dewar Advertising's creative and strategic activities.

Learning and development agency, Achiive, has appointed Sue Cosens as associate director. Sue has worked in the pharma industry for over 14 years in sales, sales training, marketing and advertising.

Cosima Zerdik has been appointed account executive at hsdcommunications. She will be working with MÛInlycke Health Care, Bard, Reckitt Benckiser and Achiive

Kerry Holmes has joined Pharmaceutical Marketing Ltd as editor of Pharmaceutical Marketing Europe. Kerry joins from MA Healthcare where she was editor of two nursing journals, Nurse Prescribing and the IJPN. She has worked in science and healthcare publishing for the past eight years.

Munro & Forster has hired two new starters: Caroline Bird and Elizabeth Willis. Caroline joins the agency as account manager from Manning Selvage & Lee. She has two years' global account media experience across a wide range of therapy areas. Elizabeth joins the agency as trainee account executive from Hill & Knowlton. In addition, Claire Jagot has been promoted to senior account manager.

Three new appointments have been made at Wells Healthcare Communications: Dr Nick Ashley, Dr Toby Galbraith and Rachel Hood. Dr Ashley has been appointed director of medical education and will be responsible for business development and strategic counsel for pre-launch products. Dr Galbraith joins the company as assistant manager, client services and will be responsible for supporting key multimedia and also vaccines accounts. Rachel has been appointed medical writer. Before joining the company she worked at the Department of Cellular and Molecular Medicine at Bristol University where she carried out research into autoimmune disease.

Obituary - Phil Cox: 1950 - 2007
Healthcare advertising has lost one of its brightest stars. Brilliant and witty, creative director of Lane, Earl & Cox Advertising, Phil Cox was the creative head behind many memorable and groundbreaking campaigns, such as the Everyday People campaign for Losec and the HIV awareness programme, TravelSafe, for the Department of Health.

Earlier, Phil was responsible for the launch of the consumer pregnancy test, Clearblue, as well as developing the campaign that introduced GP fundholding for the Department of Health. He also devised the successful British Heart Foundation ad campaigns for five years.

Phil left Exeter University with a BA Hons in English Literature and worked for several years in NHS administration, as a medical records officer and running community health centres in Bristol. Eventually, he moved to advertising and his skill with words and natural creativity made him one of the most sought after copywriters.

He worked at many leading agencies, such as JWT Deltakos, BBL&D and GA International. In 1993, Phil became one of the founding directors of Lane, Earl & Cox Advertising.

This is when the respect and admiration for him became most apparent as the agency thrived from the outset with several of Phil's previous clients turning to the agency for creative solutions. From there, the rest is history.

Outside work, Phil's interests centred on genealogy and, with his usual characteristic vigour, he was tracing his family tree and writing family history. His ambition was to be an author and historian in later life and his extreme eloquence and erudition would have stood him in good stead to achieve this goal.

Having suffered from depression for several years, the illness eventually got the better of him and tragically Phil took his own life on February 12 this year. He will always be remembered for his brilliance through his superb creative team who will continue to produce the inspired work for which Lane, Earl & Cox is best known.

Phil leaves behind his partner, Jane and daughter Julia who request that donations should be made in lieu of flowers to the housing and homelessness charity, Shelter, of which Phil was a supporter.

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera

We live in a time of participation – patients actively involved in their own care recover faster and live longer....

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics